TABLE 3.
R. capsulatus genee | Annotation | Predicted/verified function(s) and/or characteristic(s) of gene product | WT/ΔctrA ratio |
Predicted TMS (n) | Phenotype of mutant(s) |
||
---|---|---|---|---|---|---|---|
Stationarya | Logb | Transformationc | RcGTA recipient capabilityd | ||||
rcc00197 | comF | Unknown; required for DNA transport from periplasm to cytoplasm | 3.23 | 5.35 | 1 | Not detectable | Unknown |
rcc00460 | comM | Unknown; putative ATPase and helicase-like domains | 2.91 | 1.89 | 0 | Variable; 0– to 300-fold reduction | Unknown |
rcc02362 | comEC-rec2 | Integral membrane protein; transports DNA from periplasm to cytoplasm | 4.88 | 2.67 | 6 | Not detectable | Unknown |
rcc03098 | dprA | Recombination mediator; loads RecA into ssDNA | 9.38 | 3.75 | 0 | Not detectable | Not detectable |
rcc01751 | recA | Recombination protein A; RecA; DNA repair and homologous recombination | 1.47 | 1.22 | 0 | Not detectable | Not detectable |
rcc01663 | ctrA | Cell cycle transcriptional regulator CtrA; regulates transcription of RcGTA and com genes | 0.94 | 1.04 | 0 | Unknown | Not detectable |
Ratio of WT to ΔctrA microarray expression values for cells grown to the exponential phase of growth.
Ratio of WT to ΔctrA microarray gene expression values for cells grown to the stationary phase of growth.
A 107-fold reduction in transformation was used as the limit of detection in other species.
A 106-fold reduction in recipient capability was used as the limit of detection in R. capsulatus.
Shown are predicted and verified RcGTA recipient capability genes, their annotations, predicted or verified functions, expression levels in the ΔctrA mutant versus the wild type in both stationary and log phases, the numbers of predicted transmembrane segments (TMS), the phenotypes in natural transformation systems, and the phenotypes resulting from mutations in these genes in natural transformation systems and in RcGTA recipient capability. Microarray expression values are derived from data reported in reference 61, and ΔdprA, ΔrecA, and ΔctrA mutant phenotypes were reported previously by Brimacombe et al. (13).